Below are the most recent publications written about "Schizophrenic Psychology" by people in Profiles.
-
Biondo J, Gerber N, Bradt J, Du W, Goodill S. Single-Session Dance/Movement Therapy for Thought and Behavioral Dysfunction Associated With Schizophrenia: A Mixed Methods Feasibility Study. J Nerv Ment Dis. 2021 02 01; 209(2):114-122.
-
Lu MLR, De Venecia TA, Goyal A, Rodriguez Ziccardi M, Kanjanahattakij N, Shah MK, Davila CD, Figueredo VM. Psychiatric conditions as predictors of rehospitalization among African American patients hospitalized with heart failure. Clin Cardiol. 2017 Nov; 40(11):1020-1025.
-
Correll CU, Citrome L, Haddad PM, Lauriello J, Olfson M, Calloway SM, Kane JM. The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence. J Clin Psychiatry. 2016; 77(suppl 3):1-24.
-
Moore RC, Harmell AL, Harvey PD, Bowie CR, Depp CA, Pulver AE, McGrath JA, Patterson TL, Cardenas V, Wolyniec P, Thornquist MH, Luke JR, Palmer BW, Jeste DV, Mausbach BT. Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorder. Schizophr Res. 2015 Dec; 169(1-3):121-127.
-
Kohler CG, Richard JA, Brensinger CM, Borgmann-Winter KE, Conroy CG, Moberg PJ, Gur RC, Gur RE, Calkins ME. Facial emotion perception differs in young persons at genetic and clinical high-risk for psychosis. Psychiatry Res. 2014 May 15; 216(2):206-12.
-
Gollub RL, Shoemaker JM, King MD, White T, Ehrlich S, Sponheim SR, Clark VP, Turner JA, Mueller BA, Magnotta V, O'Leary D, Ho BC, Brauns S, Manoach DS, Seidman L, Bustillo JR, Lauriello J, Bockholt J, Lim KO, Rosen BR, Schulz SC, Calhoun VD, Andreasen NC. The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics. 2013 Jul; 11(3):367-88.
-
Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry. 2013 Sep 15; 74(6):436-43.
-
Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2013 Feb; 33(1):118-20.
-
Karageorgiou E, Schulz SC, Gollub RL, Andreasen NC, Ho BC, Lauriello J, Calhoun VD, Bockholt HJ, Sponheim SR, Georgopoulos AP. Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics. 2011 Dec; 9(4):321-33.
-
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. J Clin Psychopharmacol. 2011 Feb; 31(1):86-91.